Best of the financial columnists
Mar 19, 2021
3 minutes
Medics are in Big Pharma’s pockets
Jawad Iqbal
The Times
How is it legal or ethically permissible for pharmaceutical companies to “pay doctors to promote their drugs”? asks Jawad Iqbal. If adoctor recommends a treatment, patients should be confident they don’t have a “financial interest in doing so”. Yet GlaxoSmithKline doubled its payments to doctors from £9.9m to £19.3m from 2017 to 2019 across the US and Europe. In Britain, payments rose from £520,000 to £1.6m. Similar payments are made by the likes
You’re reading a preview, subscribe to read more.
Start your free 30 days